<DOC>
	<DOCNO>NCT00139347</DOCNO>
	<brief_summary>The main objective study determine vaccine efficacy severe rotavirus ( RV ) gastroenteritis ( GE ) period start 2 week Dose 2 one year age .</brief_summary>
	<brief_title>Study 2 Doses HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV Healthy Infants</brief_title>
	<detailed_description>The study two group : Group HRV Group Placebo . Two oral dos administer healthy infant 6-12 week age time Dose 1 , accord 0 , 1 2-month schedule . Routine EPI vaccination give discretion investigator accord local National Plans Immunisation schedule participate country .</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : Healthy infant 6 12 week old Dose 1 write informed consent . Exclusion criterion : Allergic reaction vaccine component ; clinically significant history chronic GI disease ( uncorrected GI congenital malformation ) serious medical condition per investigator , receive vaccine treatment prohibit protocol ; immunocompromised .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>